financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Upgrades Opinion On Shares Of Royal Bank Of Canada To Buy From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Upgrades Opinion On Shares Of Royal Bank Of Canada To Buy From Hold
May 30, 2024 7:55 AM

10:30 AM EDT, 05/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

With the Canadian economy showing weakness, we view RBC as well positioned to outperform given its scale, superior earnings profile, and demonstrated history of maneuvering through tough economic times. We increase our target price by $31 to $130, 14.6x our FY 25 (Oct.) EPS view ($8.90 converted from CAD), a wider risk premium than the peer average of 9.7x. We raise our FY 24 EPS to CAD11.55 from CAD11.51 and increase FY 25's to CAD12.20 from CAD11.91. RY posted adjusted Apr-Q EPS of CAD2.92 vs. CAD2.65 a year ago, beating the CAD2.74 consensus. Record results were seen in Capital Markets (+18%) as market share gains and strong client activity led to a 45% surge in investment banking revenue. Canadian Banking saw revenue jump 13% as results benefited from strong balance sheet growth and the HSBC Canada acquisition. Productivity improvements were seen with the bank's efficiency ratio improving 240 bps to 56.0%. Still, like other Canadian banks, RY saw its gross impaired loans rise 21 bps to 0.55%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024
11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount...
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Jun 11, 2024
01:05 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We set our 12-month target at $65, representing an estimated 2025 P/E of 43.3x. We initiate coverage at Hold, as we see adj-EPS growth to $1.10 in 2024 and $1.50...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Crowdstrike Holdings Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Crowdstrike Holdings Inc.
Jun 10, 2024
01:25 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Shares of CRWD ended the trading day on Monday up more than 7% on news that the company will be joining the S&P 500 on June 24. CRWD has been...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Jun 11, 2024
03:25 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $990 from $940, reflecting a 51.7x multiple on our 2025 EPS estimate, above LLY's historical forward P/E average. We maintain our 2024 EPS estimate at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved